Julien Gaudric

Julien Gaudric

Auto-generated profile, based on publicly available information

Julien Gaudric

Sorbonne Université, Department of Vascular Surgery, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, France

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
GHGulen Hatemi
Gulen Hatemi
RCRobin Christensen
Robin Christensen
DBDongsik Bang
Dongsik Bang
BBBahram Bodaghi
Bahram Bodaghi
ACAykut Ferhat Celik
Aykut Ferhat Celik
HYHasan Yazici
Hasan Yazici

20 January 2015 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
DSDavid SAADOUN
David SAADOUN
MGM. Garrido
M. Garrido
CCC. Comarmond
C. Comarmond
ADA. C. Desbois
A. C. Desbois
FDF. Domont
F. Domont
PCPatrice CACOUB
Patrice CACOUB
Objective: Takayasu arteritis (TAK) is a large‐vessel vasculitis that induces damage to the aorta and its branches. Glucocorticoids remain the gold standard of therapy for TAK. The nature of the T cells driving vascular inflammation and the effects of glucocorticoids on the systemic components of TAK are not understood. The aim of this study was to analyze T cell homeostasis and cytokine production in peripheral blood and inflammatory lesions of the aorta in patients with TAK.Methods: T cell homeostasis and cytokine production in peripheral blood and inflammatory lesions of the aorta were analyzed using Luminex analysis, flow cytometry, and immunohistochemical analysis. The study included 41 patients fulfilling the American College of Rheumatology 1990 criteria for the classification of TAK (17 patients with active TAK and 24 patients with disease in remission), 30 patients with giant cell arteritis and 39 patients with Behçet's disease (disease controls), and 20 age‐ and sex‐matched healthy control subjects.Results: We observed a marked increase in the expression of Th1 and Th17 cells, which correlated with TAK disease activity. The addition of serum from patients with active TAK to sorted CD4+ T cells from healthy donors in culture medium induced significant production of interferon‐γ (IFNγ) and interleukin‐17A (IL‐17A). We demonstrated the presence of IFNγ‐, IL‐6–, and IL‐17A–producing T cells in vascular inflammatory infiltrates in patients with TAK. Corticosteroid therapy was associated with decreased levels of circulating Th1 cytokines in corticosteroid‐treated patients with TAK compared with steroid‐free patients with TAK (for IL‐2, mean ± SD 5,079 ± 5,300 versus 7,359 ± 3,197 pg/ml; for IFNγ, 2,592 ± 3,072 versus 8,393 ± 3,392 pg/ml; for tumor necrosis factor α, 847 ± 724 versus 1,491 ± 392 pg/ml). However, glucocorticoids had essentially no effect on the frequency of Th17 cytokines (IL‐1 receptor, IL‐17, and IL‐23).Conclusion: The Th17 and Th1 pathways contribute to the systemic and vascular manifestations of TAK. Glucocorticoid treatment suppresses Th1 cytokines but spares Th17 cytokines in patients with TAK.

1 February 2017 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
XCXavier Chaufour
Xavier Chaufour
JGJulien Gaudric
Julien Gaudric
YGYann Goueffic
Yann Goueffic
RKRéda Hassen Khodja
Réda Hassen Khodja
PFPatrick Feugier
Patrick Feugier
ACAURC (French University Surgeons Association) collaborators
AURC (French University Surgeons Association) collaborators

28 August 2015 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
CCC. Comarmond
C. Comarmond
TMTristan Mirault
Tristan Mirault
LBL. Biard
L. Biard
JNJ. Nizard
J. Nizard
MLMarc Lambert
Marc Lambert
FNFor The French Takayasu Network
For The French Takayasu Network
Objective: To assess the relationship between Takayasu arteritis (TAK) and pregnancy outcome.Methods: This study included 240 pregnancies in 96 patients fulfilling the American College of Rheumatology 1990 criteria for the classification of TAK and/or the 1994 Chapel Hill Consensus Conference nomenclature/criteria for vasculitis. We analyzed obstetric and maternal outcomes in women who were pregnant before and/or at the same time as or after TAK diagnosis. We assessed factors associated with complicated pregnancy.Results: One hundred forty‐two pregnancies occurred in 52 patients before TAK diagnosis (median age at pregnancy 26 years [interquartile range 23–30 years]), and 98 pregnancies occurred in 52 patients concomitant with or after TAK diagnosis (median age at pregnancy 28 years [interquartile range 26–31 years]). Pregnancies concomitant with or after TAK diagnosis had a 13‐fold higher rate of obstetric complications compared to pregnancies before TAK diagnosis (odds ratio 13 [95% confidence interval 5–33], P < 0.0001). TAK was associated with a 40% frequency of obstetric complications, including preeclampsia/eclampsia (24 pregnancies [24%]), premature delivery (8 pregnancies [8%]), and intrauterine fetal growth restriction or death (5 pregnancies [5%]). Maternal complications of TAK occurred during 39% of pregnancies and included mainly new‐onset or worsening hypertension (26 pregnancies [27%]). In multivariate analysis, smoking (odds ratio 6.15 [95% confidence interval 1.31–28.8]) and disease activity of TAK (a National Institutes of Health score of >1) (odds ratio 28.7 [95% confidence interval 7.89–104.7]) were independently associated with obstetric and maternal complications.Conclusion: TAK negatively affects pregnancy outcomes. Disease activity increases the risk of obstetric and maternal complications, mainly due to arterial hypertension.

1 May 2016 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
MPMaría Teresa Politi
María Teresa Politi
AGArthur Ghigo
Arthur Ghigo
JFJuan Manuel Fernández
Juan Manuel Fernández
IKIsmaïl Khelifa
Ismaïl Khelifa
JGJulien Gaudric
Julien Gaudric
PLPierre-Yves Lagrée
Pierre-Yves Lagrée

1 August 2009 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
PBPierre Bourquelot
Pierre Bourquelot
JTJan Bijan Tawakol
Jan Bijan Tawakol
JGJulien Gaudric
Julien Gaudric
ANAna Natário
Ana Natário
GFGilbert Franco
Gilbert Franco
ARAlain Raynaud
Alain Raynaud